Vbi vaccines inc/bc (VBIV)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
CASH FLOWS FROM OPERATING ACTIVITIES
NET LOSS

-48,565

-54,813

-63,188

-62,394

-65,955

-63,600

-55,893

-50,326

-42,608

-38,995

-35,863

-33,361

-30,764

-23,205

0

0

0

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

1,486

1,204

923

640

517

542

608

665

708

730

705

679

645

606

0

0

0

Stock-based compensation

3,860

3,935

3,744

3,641

3,752

3,312

3,254

3,074

2,608

2,410

0

0

0

-

-

-

-

Amortization of debt discount

982

998

1,096

1,193

1,230

1,274

1,228

1,184

1,192

1,181

984

695

397

109

0

0

0

Deferred taxes

-

-

-

-

-

-

-

-

-

-431

-2,211

-2,211

-2,211

-1,780

0

0

0

Net change in operating working capital items:
Change in accounts receivable

15

136

61

-122

-47

-79

-73

-47

122

127

265

405

319

113

0

0

0

Change in inventory

-164

385

432

329

522

378

660

392

10

89

167

-73

167

93

0

0

0

Change in prepaid expenses

31

-326

457

-40

12

285

85

-83

278

265

0

0

0

-

-

-

-

Change in other current assets

-329

-57

-1,438

-1,613

-235

-213

1,462

1,222

241

230

379

-154

-600

-763

0

0

0

Change in other long-term assets

2

-6

14

7

6

31

51

63

8

14

210

0

251

221

0

0

0

Change in operating right of use assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in accounts payable

-3,859

-5,175

-617

-574

2,101

3,804

194

222

548

-675

0

0

0

-

-

0

0

Change in deferred revenues

-1,621

-1,694

3,590

4,072

4,556

4,924

0

0

0

-

-

-

-

-

-

-

-

Increase (decrease) in deferred revenues

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

(Decrease) increase in deferred revenues, including related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Change in other current liabilities

-1,660

374

-235

4,484

2,615

4,146

4,804

6,130

5,929

4,714

0

0

0

-

-

0

0

Payments made on operating lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows used in operating activities

-42,340

-48,712

-47,732

-47,310

-50,975

-45,533

-47,474

-39,776

-31,715

-31,381

-29,838

-27,762

-25,365

-18,517

0

0

0

INVESTING ACTIVITIES
Changes in long-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Purchase of property and equipment

1,910

3,673

5,861

6,857

6,874

5,993

3,733

2,255

1,389

640

800

775

745

585

0

0

0

Net cash flows used in investing activities

-1,910

-3,673

-5,861

-6,857

-6,874

-5,993

-3,672

-2,194

-1,328

-579

-626

-789

1,367

1,500

0

0

0

FINANCING ACTIVITIES
Proceeds from issuance of common shares for cash, upon exercise of stock options

-

-

-

-

-

65

65

65

5

16

75

75

75

59

0

0

0

Repayment of long-term debt

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows used in financing activities

0

-

-

-

-

43,617

67,287

67,287

67,227

67,238

23,264

23,039

36,499

36,483

0

0

0

Effect of exchange rates on cash

-70

-87

-423

-437

-549

-515

0

0

0

-

-

-

-

-

-

-

-

CHANGE IN CASH FOR THE PERIOD

-7,505

-15,057

27,030

-11,052

-14,786

-8,424

0

0

0

-

-

-

-

-

-

-

-

Effect of exchange rates on cash

-

-

-

-

-

-

-

-

-

-

539

-654

48

340

0

0

0

CHANGE IN CASH FOR THE PERIOD

-

-

-

-

-

-

-

-

-

-

-6,688

-6,166

12,549

19,806

0

0

0

Supplementary information:
Interest paid - related party

1,990

2,033

2,050

2,044

2,024

1,980

1,944

1,910

1,874

1,850

0

0

0

-

-

-

-

Cash paid during the period for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Non-cash investing and financing activities:
Warrant modification in connection with debt amendment

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures included in accounts payable and other current liabilities

-915

33

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures included in other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0